萬興科技(300624.SZ):目前產品已覆蓋桌面端、移動端和在線端,可滿足用户多場景下的文檔創作、編輯、閲讀、翻譯、保護等多樣需求
格隆匯5月21日丨萬興科技(300624.SZ)在互動平台表示,公司旗下文檔創意產品萬興PDF/PDFelement提供PDF編輯、轉換、OCR、簽名及AI對話、知識卡片、總結、翻譯等全面功能,以行業領先的PDF處理能力為基礎,不斷融合新興技術,拓展產品能力邊界,致力於為用户提供簡單高效的智慧文檔服務。目前產品已覆蓋桌面端、移動端和在線端,可滿足用户多場景下的文檔創作、編輯、閲讀、翻譯、保護等多樣需求,全面提升辦公效率和智能化工作體驗。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.